Can folic acid protect against congenital heart defects in Down syndrome?

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 76, Issue 10, 2006, Pages 714-717

  Meijer, Willemijn M ^a,b   Werler, Martha M ^a   Louik, Carol ^a   Hernandez Diaz, Sonia ^a,c   De Jong Van Den Berg, Lolkje T W ^b   Mitchell, Allen A ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Birth defects; Case control study; Down syndrome; Folic acid; Heart anomalies

Indexed keywords

FOLIC ACID;

ARTICLE; CASE CONTROL STUDY; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOWN SYNDROME; ENDOCARDIAL CUSHION DEFECT; FEMALE; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION;

DIETARY SUPPLEMENTS; DOWN SYNDROME; FEMALE; FOLIC ACID; FOOD, FORTIFIED; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RETROSPECTIVE STUDIES;

EID: 33750438116     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20312     Document Type: Article

References (16)

1. Botto LD, Mulinare J, Erickson JD. 2000. Occurrence of congenital heart defects in relation to maternal multivitamin use. Am J Epidemiol 151:878-884.
2. Czeizel AE. 1998. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol 78:151-161.
3. Czeizel AE, Puhó E. 2005. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: a case-control study. Nutrition 21:698-704.
4. Fixler DE, Threlkeld N. 1998. Prenatal exposures and congenital heart defects in Down syndrome infants. Teratology 58:6-12.
5. Freeman SB, Taft LF, Dooley KJ, et al. 1998. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 80:213-217.
6. Hernandez-Diaz S, Werler MM, Walker AM, et al. 2000. Folic acid antagonists during pregnancy and the risk of birth defects. New Engl J Med 343:1608-1614.
7. Hobbs CA, Sherman SL, Yi P, et al. 2000. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 67:623-630.
8. James SJ, Pogribna M, Pogribny IP, et al. 1999. Abnormal folate metabolism and mutation in the methylenetertrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70:495-501.
9. Källèn B, Mastroiacovo P, Robert E. 1996. Major congenital malformations in Down syndrome. Am J Med Genet 65:160-166.
10. Khoury MJ, Erickson JD. 1992. Can maternal risk factors influence the presence of major birth defects in infants with Down syndrome? Am J Med Genet 43:1016-1022.
11. Meijer WM, De Walle HEK, Kerstjens-Frederikse WS, et al. 2005. Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Reprod Toxicol 20:203-207.
12. Mitchell AA, Rosenberg L, Shapiro S, et al. 1981. Birth defects related to Bendectin use during pregnancy: I, oral clefts and cardiac defects. JAMA 245:2311-2314.
13. Petersen M, Grigoriadou M, Mikkelsen M. 2000. A common mutation in the methylenetetrahydrofolate reductase gene is not a risk factor for Down syndrome. Am J Hum Genet 67 Suppl 2:141.
14. Shapiro BL. 1983. Down syndrome-A disruption of homeostasis. Am J Med Genet 14:241-269.
15. Torfs CP, Christianson RE. 1999. Maternal risk factors and major associated defects in infants with Down syndrome. Epidemiology 10:264-270.
16. Werler MM, Hayes C, Louik C, et al. 1999. Multivitamin supplementation and risk of birth defects. Am J Epidemiol 150:675-682.